menu
    • menu

    Company profile for BriaCell Therapeutics

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dedicated to enhance the lives of women who are facing limited breast cancer therapy options, BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V)’s mission has been to develop novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy the cancer cells, offering the potential for higher levels of safety and efficacy than c...
    Dedicated to enhance the lives of women who are facing limited breast cancer therapy options, BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V)’s mission has been to develop novel immunotherapies to fight cancer. Immunotherapies have become the forefront of the cancer treatments because they use the body’s immune system to destroy the cancer cells, offering the potential for higher levels of safety and efficacy than chemotherapy and which may prevent cancer recurrence.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BriaCell TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    Suite 300 - Bellevue Centre, 235 -15th Street, West Vancouver, BC V7T 2X1
    Telephone
    Telephone
    +1604-921-1810
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://briacell.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BriaCell Announces Six Clinical Data Presentations At ASCO 2026
    BriaCell Announces Six Clinical Data Presentations At ASCO 2026

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7211236

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    BriaCell Shares Positive Ph3 QoL & Ph2 Data in 2026
    BriaCell Shares Positive Ph3 QoL & Ph2 Data in 2026

    20 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/20/3276889/0/en/briacell-presents-positive-phase-3-quality-of-life-and-phase-2-biomarker-data-at-the-2026-aacr-meeting.html

    GLOBENEWSWIRE
    20 Apr 2026
    Share Share
    BriaCell Closes Asset Deal for Exclusive Soluble CD80 License
    BriaCell Closes Asset Deal for Exclusive Soluble CD80 License

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266014/0/en/BriaCell-and-BriaPro-Announce-Closing-of-Asset-Purchase-Transaction-for-Exclusive-Soluble-CD80-License.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Briacell To Unveil Clinical And Preclinical Data At 2026 AACR
    Briacell To Unveil Clinical And Preclinical Data At 2026 AACR

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258061/0/en/BriaCell-to-Present-Positive-Clinical-Data-for-Bria-IMT-and-Preclinical-Data-for-Next-Generation-Bria-OTS-Personalized-Immunotherapy-at-the-2026-AACR-Conference.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    BriaCell To Showcase Four Posters At 2026 AACR Meeting
    BriaCell To Showcase Four Posters At 2026 AACR Meeting

    10 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/10/3252671/0/en/BriaCell-to-Present-Four-Poster-Presentations-at-the-2026-AACR-Annual-Meeting.html

    GLOBENEWSWIRE
    10 Mar 2026
    Share Share
    Briacell Therapeutics Reveals Shareholder Meeting Outcomes
    Briacell Therapeutics Reveals Shareholder Meeting Outcomes

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250650/0/en/BriaCell-Therapeutics-Corp-Announces-Results-of-Shareholder-Meeting.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search